LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | BI-2536 | 3.33 | uM | LJP6 | 72 | hr | 962 | 905 | 10605 | 0.0854 | -0.0059 |
MCF 10A | BMS345541 | 3.33 | uM | LJP6 | 72 | hr | 962 | 10231 | 10605 | 0.9648 | 0.9612 |
MCF 10A | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 962 | 273 | 10605 | 0.0258 | -0.0714 |
MCF 10A | GDC-0980 | 3.33 | uM | LJP5 | 72 | hr | 962 | 1254 | 10605 | 0.1183 | 0.0303 |
MCF 10A | NVP-AEW541 | 3.33 | uM | LJP5 | 72 | hr | 962 | 8808 | 10605 | 0.8306 | 0.8137 |
MCF 10A | SB590885 | 3.33 | uM | LJP5 | 72 | hr | 962 | 9798 | 10605 | 0.9240 | 0.9164 |
MCF 10A | PIK-93 | 3.33 | uM | LJP5 | 72 | hr | 962 | 8566 | 10605 | 0.8078 | 0.7886 |
MCF 10A | KIN001-043 | 3.33 | uM | LJP6 | 72 | hr | 962 | 8700 | 10605 | 0.8204 | 0.8024 |
MCF 10A | Alpelisib | 3.33 | uM | LJP5 | 72 | hr | 962 | 8262 | 10605 | 0.7791 | 0.7571 |
MCF 10A | Luminespib | 3.33 | uM | LJP5 | 72 | hr | 962 | 816 | 10605 | 0.0770 | -0.0151 |
MCF 10A | A443654 | 3.33 | uM | LJP6 | 72 | hr | 962 | 316 | 10605 | 0.0298 | -0.0670 |
MCF 10A | OSI-027 | 3.33 | uM | LJP6 | 72 | hr | 962 | 1575 | 10605 | 0.1485 | 0.0636 |
MCF 10A | XMD11-85h | 3.33 | uM | LJP6 | 72 | hr | 962 | 10124 | 10605 | 0.9547 | 0.9502 |
MCF 10A | HG-6-64-01 | 3.33 | uM | LJP6 | 72 | hr | 962 | 6155 | 10605 | 0.5804 | 0.5386 |
MCF 10A | WH-4-025 | 3.33 | uM | LJP5 | 72 | hr | 962 | 2523 | 10605 | 0.2379 | 0.1619 |
MCF 10A | WZ-4-145 | 3.33 | uM | LJP6 | 72 | hr | 962 | 5531 | 10605 | 0.5216 | 0.4739 |
MCF 10A | XMD16-144 | 3.33 | uM | LJP5 | 72 | hr | 962 | 1265 | 10605 | 0.1193 | 0.0314 |
MCF 10A | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 962 | 7242 | 10605 | 0.6829 | 0.6512 |
MCF 10A | Buparlisib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1383 | 10605 | 0.1304 | 0.0436 |
MCF 10A | BX-912 | 3.33 | uM | LJP5 | 72 | hr | 962 | 1609 | 10605 | 0.1518 | 0.0671 |
MCF 10A | Canertinib | 3.33 | uM | LJP6 | 72 | hr | 962 | 1509 | 10605 | 0.1423 | 0.0567 |
MCF 10A | Celastrol | 3.33 | uM | LJP6 | 72 | hr | 962 | 374 | 10605 | 0.0353 | -0.0609 |
MCF 10A | CGP60474 | 3.33 | uM | LJP5 | 72 | hr | 962 | 292 | 10605 | 0.0275 | -0.0695 |
MCF 10A | CGP60474 | 3.33 | uM | LJP6 | 72 | hr | 962 | 238 | 10605 | 0.0224 | -0.0751 |
MCF 10A | CHIR-99021 | 3.33 | uM | LJP6 | 72 | hr | 962 | 10194 | 10605 | 0.9612 | 0.9574 |